Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / ISIN
-
Number of holders
-
218
-
Total shares
-
76.7M
-
Shares change
-
-102K
-
Total reported value, excl. options
-
$635M
-
Value change
-
+$1.07M
-
Put/Call ratio
-
0.69
-
Number of buys
-
102
-
Number of sells
-
-87
-
Price
-
$8.27
Significant Holders of SORRENTO THERAPEUTICS INC - ISIN (SRNE) as of Q1 2021
225 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - ISIN as of Q1 2021.
SORRENTO THERAPEUTICS INC - ISIN (SRNE) has 218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76.7M shares
.
Largest 10 shareholders include BlackRock Inc. (19.4M shares), VANGUARD GROUP INC (13.6M shares), STATE STREET CORP (9.79M shares), GEODE CAPITAL MANAGEMENT, LLC (4.05M shares), Cormorant Asset Management, LP (2.75M shares), NORTHERN TRUST CORP (2.75M shares), JPMORGAN CHASE & CO (2.38M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1.64M shares), Nuveen Asset Management, LLC (1.1M shares), and SABBY MANAGEMENT, LLC (1.06M shares).
This table shows the top 218 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.